Global Monoclonal Antibodies in Veterinary Health Market
The global Monoclonal Antibodies in Veterinary Health market was valued at USD 0.77 billion in 2021 which expected to reach USD 2.47 billion by 2027 at a CAGR 16.27%from 2021-2027.
Monoclonal antibodies are medications that act like your own antibodies and can assist to keep your symptoms from worsening and may prevent hospitalization due to worsening COVID-19 symptoms. This is NOT a vaccine replacement; rather, it is used to treat your present COVID-19 infection. The rising prevalence of atopic dermatitis, as well as the rising pet adoption rate, are driving market expansion. Furthermore, increased R&D spending by market participants for the development of cancer treatments is expected to fuel market expansion over the forecast period.
Market Drivers
The increasing frequency of canine atopic dermatitis is also predicted to function as a driving factor in market expansion. Canine atopic dermatitis is a genetic clinical condition that affects domestic dogs. Furthermore, atopic dermatitis is the most common cause of itchy allergic skin illness in dogs. According to Frontiers Media S.A. research published in October 2020, the disease is predicted to impact 10-15% of the canine population. According to the publication, this figure is anticipated to rise over time. Market participants like Zoetis have goods like Cytopoint, the first monoclonal antibody treatment for allergic and atopic dermatitis.
Impact of COVID-19
Despite the protracted lockdowns and supply chain interruptions caused by the COVID-19 outbreak, market participants reported no decrease in income. For example, Zoetis reported a 22% growth in dermatology segment revenue from 2019 to 2020, and a 25% increase from 2020 to 2021. Pet adoption, on the other hand, has increased. During the first quarter of the pandemic, there was a 50% increase in pet adoption in the United States. This resulted in an increase in the number of pet households, as well as expenditures on them, including medical expenses.
Market Segmentation
The Global Monoclonal Antibodies in Veterinary Health Market is segmented into Application, Animal Type, Distribution Channel and Growing System. By Application such as Dermatology, Pain, Others. By Animal Type such as Dogs, Others. By End-User such as Veterinary Hospitals, Others.
Regional Analysis
Global Monoclonal Antibodies in Veterinary Health Market is segmented into five regions such as North America, Latin America, Europe, Asia Pacific, and Middle East & Africa. During the forecast period, the Monoclonal Antibodies in Veterinary Health market in North America is expected to grow at the fastest CAGR. This is due to the different programmes launched by the government and commercial sector, as well as the growing popularity of pet insurance. Furthermore, the presence of important organizations in the United States is expected to support market growth. According to the North American Pet Health Insurance Association, Inc., the pet insurance sector has grown at a significant pace of 23.4% in recent years. Furthermore, by the end of 2020, around 3.45 million pets were covered across North America.
The Asia Pacific market is expected to develop at the fastest CAGR during the forecast period, owing to the increasing emergence of local companies and the growing number of veterinary hospitals and clinics. Furthermore, the growing adoption of pets, as well as increased knowledge of their ailments and the availability of treatment choices, are projected to drive market expansion.
Key Players
Various key players are listed in this report such as Zoetis; Merck & Co, Inc.; Elanco; Boehringer Ingelheim GmbH; Indian Immunologicals Ltd; Virbac
Market Taxonomy
By Application
By Animal Type
By End-User
By Region
Key Questions Addressed by the Report
Global Monoclonal Antibodies in Veterinary Health Market TOC
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Global Monoclonal Antibodies in Veterinary Health Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Global Monoclonal Antibodies in Veterinary Health Market, By Application
5.1 Y-o-Y Growth Comparison, By Application
5.2 Global Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Application
5.3 Global Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Application
5.3.1 Dermatology
5.3.2 Pain
5.3.3 Others
6 Global Monoclonal Antibodies in Veterinary Health Market, By Animal Type
6.1 Y-o-Y Growth Comparison, By Animal Type
6.2 Global Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Animal Type
6.3 Global Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Animal Type
6.3.1 Dogs
6.3.2 Others
7 Global Monoclonal Antibodies in Veterinary Health Market, By End-User
7.1 Y-o-Y Growth Comparison, By End-User
7.2 Global Monoclonal Antibodies in Veterinary Health Market Share Analysis, By End-User
7.3 Global Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By End-User
7.3.1 Veterinary Hospitals
7.3.2 Others
8 Global Monoclonal Antibodies in Veterinary Health Market, By Region
8.1 Global Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Region
8.2 Global Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Region
8.3 Global Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Region
9 North America Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
9.1 Introduction
9.2 North America Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Application
9.3 North America Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Animal Type
9.4 North America Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By End-User
9.6 North America Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Country
9.7.1 U.S.
9.7.2 Canada
9.7.3 Mexico
10 Europe Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
10.1 Introduction
10.2 Europe Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Application
10.3 Europe Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Animal Type
10.4 Europe Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By End-User
10.6 Europe Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Country
10.6.1 Germany
10.6.2 France
10.6.3 UK
10.6.4. Rest of Europe
11 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
11.1 Introduction
11.2 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Application
11.3 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Animal Type
11.4 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By End-User
11.6 Asia Pacific Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Country
11.6.1 China
11.7.2 Japan
11.8.3 India
11.8.4. Rest of Asia Pacific
12 Latin America Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
12.1 Introduction
12.2 Latin America Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Application
12.3 Latin America Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Animal Type
12.4 Latin America Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By End-User
12.6 Latin America Monoclonal Antibodies in Veterinary Health Market Size and Forecast, Country
12.7.1. Brazil
12.8.2. Rest of Latin America
13 Middle East Monoclonal Antibodies in Veterinary Health Market Analysis and Forecast (2021-2027)
13.1 Introduction
13.2 Middle East Monoclonal Antibodies in Veterinary Health Market Share Analysis, By Application
13.3 Middle East Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Animal Type
13.4 Middle East Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By End-User
13.6 Middle East Monoclonal Antibodies in Veterinary Health Market Size and Forecast, By Country
13.7.1. Saudi Arabia
13.8.2. UAE
13.8.3. Egypt
13.9.4. Kuwait
13.10.5. South Africa
14 Competitive Analysis
14.1 Competition Dashboard
14.2 Market share Analysis of Top Vendors
14.3 Key Development Strategies
15 Company Profiles
15.1 Zoetis
15.1.1 Overview
15.1.2 Applications
15.1.3 Key Financials
15.1.4 Business Segment & Geographic Overview
15.1.5 Key Market Developments
15.1.6 Key Strategies
15.2. Merck & Co, Inc
15.2.1 Overview
15.2.2 Applications
15.2.3 Key Financials
15.2.4 Business Segment & Geographic Overview
15.2.5 Key Market Developments
15.2.6 Key Strategies
15.3. Elanco
15.3.1 Overview
15.3.2 Applications
15.3.3 Key Financials
15.3.4 Business Segment & Geographic Overview
15.3.5 Key Market Developments
15.3.6 Key Strategies
15.4 Boehringer Ingelheim GmbH
15.4.1 Overview
15.4.2 Applications
15.4.3 Key Financials
15.4.4 Business Segment & Geographic Overview
15.4.5 Key Market Developments
15.4.6 Key Strategies
15.5 Indian Immunologicals Ltd
15.5.1 Overview
15.5.2 Applications
15.5.3 Key Financials
15.5.4 Business Segment & Geographic Overview
15.5.5 Key Market Developments
15.5.6 Key Strategies
15.6 Virbac
15.6.1 Overview
15.6.2 Applications
15.6.3 Key Financials
15.6.4 Business Segment & Geographic Overview
15.6.5 Key Market Developments
15.6.6 Key Strategies
